Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liwei Meng

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cell Death & Disease|December 14, 2020
LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progressionLiwei Meng, Zhaoquan Xing, Zhaoxin Guo, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2019
Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicinLiwei Meng, Liming Huang, Yingchun Xu, et al.
Journal of Environmental Sciences (China)|October 1, 2022
Effect of reduction pretreatments on PdAg/Al<sub>2</sub>O<sub>3</sub> for HCHO and CO oxidationLiwei Meng, Xue Han, Lian Yu, et al.
Oncotargets and Therapy|October 28, 2016
Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validationLiwei Meng, Yingchun Xu, Chaoyang Xu, et al.
Oncology Letters|April 26, 2014
Papillary thyroid cancer coexisting with thyroid tuberculosis: A case reportLiwei Meng, Shan Hu, Liming Huang, et al.
Histology and Histopathology|June 1, 2012
Arterial carbon dioxide partial pressure influences CYP4A distribution in the rat brainLi Qi, LiWei Meng, YiFei Li, et al.
Aging|March 20, 2021
Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting <i>FOXO3</i>Liwei Meng, Zhaoquan Xing, Zhaoxin Guo, et al.
Frontiers in Oncology|November 9, 2023
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developmentsJie Qiu, Da Qian, Yuancong Jiang, et al.
Aging|May 10, 2021
MiR-205 suppressed the malignant behaviors of breast cancer cells by targeting CLDN11 via modulation of the epithelial-to-mesenchymal transitionYupeng Shen, Yingchun Xu, Liming Huang, et al.
Cancer Cell International|June 11, 2020
LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathwayLiwei Meng, Zhonghai Li, Ye Chen, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cell Death & Disease|December 14, 2020
LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progressionLiwei Meng, Zhaoquan Xing, Zhaoxin Guo, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2019
Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicinLiwei Meng, Liming Huang, Yingchun Xu, et al.
Journal of Environmental Sciences (China)|October 1, 2022
Effect of reduction pretreatments on PdAg/Al<sub>2</sub>O<sub>3</sub> for HCHO and CO oxidationLiwei Meng, Xue Han, Lian Yu, et al.
Oncotargets and Therapy|October 28, 2016
Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validationLiwei Meng, Yingchun Xu, Chaoyang Xu, et al.
Oncology Letters|April 26, 2014
Papillary thyroid cancer coexisting with thyroid tuberculosis: A case reportLiwei Meng, Shan Hu, Liming Huang, et al.
Histology and Histopathology|June 1, 2012
Arterial carbon dioxide partial pressure influences CYP4A distribution in the rat brainLi Qi, LiWei Meng, YiFei Li, et al.
Aging|March 20, 2021
Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting <i>FOXO3</i>Liwei Meng, Zhaoquan Xing, Zhaoxin Guo, et al.
Frontiers in Oncology|November 9, 2023
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developmentsJie Qiu, Da Qian, Yuancong Jiang, et al.
Aging|May 10, 2021
MiR-205 suppressed the malignant behaviors of breast cancer cells by targeting CLDN11 via modulation of the epithelial-to-mesenchymal transitionYupeng Shen, Yingchun Xu, Liming Huang, et al.
Cancer Cell International|June 11, 2020
LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathwayLiwei Meng, Zhonghai Li, Ye Chen, et al.
Pageof 4